RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+11.82%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.05B
AUM Growth
+$1.05B
(+8.4%)
Cap. Flow
+$5.19M
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
49.49%
Holding
61
New
15
Increased
22
Reduced
15
Closed
7
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$26.6M |
| 2 |
Molina Healthcare
MOH
|
$25.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$23.6M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$19.8M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$18.6M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$51.7M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$50.7M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$33.8M |
| 4 |
AGN
Allergan plc
AGN
|
$30.7M |
| 5 |
Penumbra
PEN
|
$24.1M |
Sector Composition
| 1 | Healthcare | 73.5% |
| 2 | Financials | 2.71% |
| 3 | Communication Services | 2.42% |
| 4 | Industrials | 0.75% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $68.2M | 6.51% | 19,150,650 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $60.6M | 5.79% | 11,106,446 +388,026 | +4% | +$2.12M |
|
|
MDVN
3
DELISTED
MEDIVATION, INC.
MDVN
| $56.1M | 5.35% | 929,529 -857,070 | -48% | -$51.7M |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $55.8M | 5.33% | 1,381,477 +411,356 | +42% | +$16.6M |
|
5
Atara Biotherapeutics
ATRA
$84.6M
| $54.2M | 5.18% | 2,408,970 +133,205 | +6% | +$3M |
|
|
6
Penumbra
PEN
$10.6B
| $51.4M | 4.91% | 863,581 -404,386 | -32% | -$24.1M |
|
|
ELGX
7
DELISTED
Endologix Inc
ELGX
| $49.4M | 4.72% | 3,962,753 +1,493,906 | +61% | +$18.6M |
|
|
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
| $42.5M | 4.06% | 3,097,850 -1,486 | -0% | -$20.4K |
|
|
9
Molina Healthcare
MOH
$9.8B
| $42.2M | 4.03% | 845,360 +516,347 | +157% | +$25.8M |
|
|
ITCI
10
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $37.7M | 3.6% | 971,565 -84,494 | -8% | -$3.28M |
|
|
PTLA
11
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $34.6M | 3.31% | 1,466,537 +576,930 | +65% | +$13.6M |
|
|
NVRO
12
DELISTED
NEVRO CORP.
NVRO
| $29.4M | 2.81% | 398,371 +267,800 | +205% | +$19.8M |
|
13
Boston Scientific
BSX
$156B
| $28.8M | 2.75% | 1,230,320 -102,200 | -8% | -$2.39M |
|
|
14
SPDR S&P Biotech ETF
XBI
$5.07B
| $26.6M | 2.54% | +490,900 | New | +$26.6M |
|
|
MODN
15
DELISTED
MODEL N, INC.
MODN
| $25.4M | 2.42% | 1,900,659 +15,300 | +0.8% | +$204K |
|
16
BioMarin Pharmaceuticals
BMRN
$11.2B
| $25.1M | 2.4% | 322,394 -155,893 | -33% | -$12.1M |
|
|
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
| $24.6M | 2.35% | 1,949,185 +86,150 | +5% | +$1.09M |
|
18
Incyte
INCY
$16.5B
| $24.2M | 2.31% | 302,307 +85,713 | +40% | +$6.86M |
|
19
Brookdale Senior Living
BKD
$1.83B
| $23.9M | 2.28% | 1,545,331 +116,400 | +8% | +$1.8M |
|
|
ALXN
20
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23.6M | 2.26% | +202,400 | New | +$23.6M |
|
|
HTWR
21
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $23.4M | 2.24% | 405,497 +190,726 | +89% | +$11M |
|
22
Wave Life Sciences
WVE
$1.53B
| $22.7M | 2.16% | 1,095,473 -142,800 | -12% | -$2.95M |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $22.4M | 2.14% | 183,225 -8,400 | -4% | -$1.03M |
|
24
Centene
CNC
$14.3B
| $20.4M | 1.94% | 285,143 -185,406 | -39% | -$13.2M |
|
25
Prothena Corp
PRTA
$441M
| $17M | 1.63% | +487,406 | New | +$17M |
|